MHLW approves first three-year oral FLT3 inhibitor Vanflytinib to be launched
-
Last Update: 2020-06-09
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
AML is a rapidly developing blood and bone marrow cancer, and cancerous white blood cells in patients are growing rapidly, not only do they fail to function normally, but also affect the production of normal blood cellsThe 5-year survival rate for AML patients is the lowest of any leukemia typetoday, Daiichi Sankyocompany(http:// announcedthat Japan's Ministry of Health, Labour (MHLW) has approved the company's development of the oral FLT3 inhibitor Vanflyta (quizartinib) to treat recurrent/incurable (R/R) acute myeloid leukemia (AML) patientsthese patients carried FLT3-ITD gene variantsAbout Vanflyta
Vanflyta is an oral FLT3 inhibitorIt has been granted breakthrough therapeutic certification and fast-track eligibility by theFDA(http://Vanflyta was approved in Japan based on the results of a key Global Phase 3 ClinicalTrial(http://and a Phase 2 clinical trial for the treatment of Japanese patientsThe results of the QuANTUM-R trial were recently published in The Lancet Oncologyresults showed that Vanflyta significantly improved the overall survival of patients compared to salvage chemotherapyThe total lifetime of the Vanflyta patient group was 6.2 months and the control group was 4.7 months (HR: 0.75, 95% CI: 0.58, 0.98)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
